MedTrace Logo

India HIV-CervCa Project

NCT07167069 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2025-09-11

No results posted yet for this study

Summary

The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.

Conditions

Interventions

RADIATION

Radiation Therapy

Standard of Care Chemoradiation for Cervical cancer patients in India.

Sponsors & Collaborators

  • Tata Memorial Hospital

    collaborator OTHER_GOV

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Surbhi Grover, MD, MPH · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-09
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07167069 on ClinicalTrials.gov